Litcius/Paper detail

Praziquantel efficacy, urinary and intestinal schistosomiasis reinfection – a systematic review

Isaac Frimpong Aboagye, Yvonne Abena Afadua Addison

2022Pathogens and Global Health27 citationsDOIOpen Access PDF

Abstract

infections in children. Majority of both intestinal and urinary schistosomiasis studies reported comparable egg reduction rates (ERRs) of 94.2% to 99.9% and 91.9% to 98%, respectively. However, ERRs suggestive of sub-optimal PZQ efficacy as well as generally high and comparable cure rates for intestinal (81.2%-99.1%) and urinary (79%-93.7%) schistosomiasis studies were reported. Schistosomiasis reinfection rates varied widely for urinary (8.1%-39.6%) and intestinal (13.9%-63.4%) studies within eight to 28 weeks following PZQ treatment. Praziquantel treatment of urinary and intestinal schistosomiasis should be accompanied by the provision of potable water, toilet, and recreational facilities to reduce reinfection and egg reduction rates and increase cure rate to expedite schistosomiasis elimination.

Topics & Concepts

PraziquantelSchistosomiasisSchistosoma haematobiumMedicineSchistosoma mansoniSchistosomaHelminthiasisInternal medicineImmunologyGastroenterologyHelminthsParasites and Host InteractionsGlobal Maternal and Child HealthChild Nutrition and Water Access